These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34664547)

  • 21. The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study.
    Hamel R; Köhler S; Sistermans N; Koene T; Pijnenburg Y; van der Flier W; Scheltens P; Aalten P; Verhey F; Visser PJ; Ramakers I
    Psychol Med; 2015 May; 45(7):1509-19. PubMed ID: 25407094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients.
    Almkvist O; Brüggen K; Nordberg A
    J Alzheimers Dis; 2021; 81(4):1613-1624. PubMed ID: 33967046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.
    Eppig JS; Edmonds EC; Campbell L; Sanderson-Cimino M; Delano-Wood L; Bondi MW;
    J Int Neuropsychol Soc; 2017 Aug; 23(7):564-576. PubMed ID: 28578726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy.
    Barban F; Annicchiarico R; Pantelopoulos S; Federici A; Perri R; Fadda L; Carlesimo GA; Ricci C; Giuli S; Scalici F; Turchetta CS; Adriano F; Lombardi MG; Zaccarelli C; Cirillo G; Passuti S; Mattarelli P; Lymperopoulou O; Sakka P; Ntanasi E; Moliner R; Garcia-Palacios A; Caltagirone C
    Int J Geriatr Psychiatry; 2016 Apr; 31(4):340-8. PubMed ID: 26205305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
    Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
    J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Am J Geriatr Psychiatry; 2021 Mar; 29(3):272-284. PubMed ID: 32863138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological correlates of apathy in mild cognitive impairment and Alzheimer's disease: the role of executive functioning.
    Drijgers RL; Verhey FR; Leentjens AF; Köhler S; Aalten P
    Int Psychogeriatr; 2011 Oct; 23(8):1327-33. PubMed ID: 21729413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential associations between depression and cognitive function in MCI and AD: a cross-sectional study.
    Lee CH; Kim DH; Moon YS
    Int Psychogeriatr; 2019 Aug; 31(8):1151-1158. PubMed ID: 30696505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    Marra C; Piccininni C; Masone Iacobucci G; Caprara A; Gainotti G; Costantini EM; Callea A; Venneri A; Quaranta D
    J Alzheimers Dis; 2021; 81(2):619-627. PubMed ID: 33814440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular disease, Alzheimer's disease biomarkers and cognition in mild cognitive impairment: additive or synergetic effects?
    Nordlund A; Göthlin M; Wallin A
    Dement Geriatr Cogn Disord; 2011; 32(4):250-6. PubMed ID: 22179302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-photon emission computed tomography (SPECT) perfusion and neuropsychological performance in mild cognitive impairment.
    Van Patten R; Greif T; Britton K; Tremont G
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):530-543. PubMed ID: 30880594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
    Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
    Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive dysfunction characteristics of multiple sclerosis with aging.
    Vidorreta-Ballesteros L; Matias-Guiu JA; Delgado-Álvarez A; Delgado-Alonso C; Valles-Salgado M; Cuevas C; Gil-Moreno MJ; García-Ramos R; Montero-Escribano P; Matias-Guiu J
    Mult Scler Relat Disord; 2024 Jul; 87():105678. PubMed ID: 38728960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.